NKTR | DekaBank Deutsche Girozentrale Takes Position in Nektar Therapeutics (NASDAQ:NKTR)

DekaBank Deutsche Girozentrale purchased a new stake in Nektar Therapeutics (NASDAQ:NKTR) in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC).The firm purchased 56,700 shares of the biopharmaceutical company’s stock, valued at approximately $941,000.Several other hedge funds have also recently made changes […]Daily Political